Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

During the Trading Day
118.70 +0.86 / +0.73%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
118.70 0.00 / 0.00%
 
Volume: 8.9K

Today’s Trading

Previous close117.84
Today’s open116.80
Day’s range114.73 - 120.68
Volume717,177
Average volume (3 months)807,523
Market cap$9.9B
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book9.72

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.18-0.25%
ISISIsis Pharmaceuticals...-0.70-1.25%
ICLRICON PLC+0.19+0.28%
DYAXDyax Corp+0.31+1.18%
Data as of 4:06pm ET, 07/06/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers